Amathus Therapeutics
PrivateLast Round
Corporate Funding
Mar 17, 2021
Company Overview
Amathus Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Corporate Funding round in March 2021.
Amathus Therapeutics is a biotechnology company that develops small-molecule therapeutics targeting organelle-specific chaperones for the treatment of neurodegenerative and renal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amathus Therapeutics Comparables
Compare Amathus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vincere Biosciences | 89% | |
| MitoRx Therapeutics | 81% | |
| Pretzel Therapeutics | 80% |
For institutional investors. Book with your work email.
Amathus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Mar 17, 2021 |
For institutional investors. Book with your work email.
Amathus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sanofi Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2021
Merck & Co., Inc. led the corporate funding round.
For institutional investors. Book with your work email.
Amathus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amathus Therapeutics's valuation, stock price, and market status.
Is Amathus Therapeutics a public or private company?
Amathus Therapeutics is a private company.
What is the current stock price of Amathus Therapeutics?
Amathus Therapeutics is a private company, so its shares have no public market price. Caplight tracks Amathus Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amathus Therapeutics worth (valuation)?
Valuation information for Amathus Therapeutics is not publicly available.
Can I buy Amathus Therapeutics stock?
Amathus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amathus Therapeutics's last funding round?
Amathus Therapeutics's most recent funding round was Corporate Funding on March 17, 2021.
Who are the main investors in Amathus Therapeutics?
Key investors in Amathus Therapeutics include Sanofi Ventures.
Will Amathus Therapeutics IPO soon?
No public IPO plans have been announced for Amathus Therapeutics.
How can I track Amathus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Amathus Therapeutics's shares on secondary markets.